Utama › Mesotelioma › Texas › Houston
Kajian klinikal Mesotelioma di Houston, TX
15 kajian untuk Mesotelioma sedang mencari peserta di lokasi dalam dan sekitar Houston (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
SW-682 in Advanced Solid Tumors
Mengambil pesertaFasa 1
- U.T. MD Anderson Cancer Center, Houston
Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma
Mengambil pesertaFasa 1/2Sukarelawan sihat dialu-alukan
- Baylor St Lukes, Houston
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Mengambil pesertaFasa 1
- MD Anderson, Houston
- NEXT Oncology Houston, Houston
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1
- The University of Texas MD Anderson Cancer Center, Houston
TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma
Mengambil pesertaFasa 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Mengambil pesertaFasa 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Mengambil pesertaFasa 1
- MDACC, Houston
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Mengambil pesertaFasa 1/2
- MD Anderson Cancer Center, Houston
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
Mengambil pesertaFasa 1
- MD Anderson Cancer Center, Houston
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Mengambil pesertaFasa 1/2
- MD Anderson Cancer Center, Houston
A Study of VET3-TGI in Patients With Solid Tumors
Mengambil pesertaFasa 1
- University of Texas MD Anderson Cancer Center, Houston
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- MD Anderson Cancer Center, Houston
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Mengambil pesertaFasa 1/2
- The University of Texas MD Anderson Cancer Center (site 127), Houston
A Study of NX-1607 in Adults With Advanced Malignancies
Mengambil pesertaFasa 1
- MD Anderson Cancer Center, Houston
A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors
Mengambil pesertaFasa 1
- MD Anderson Cancer Center, Houston
Kajian Mesotelioma di bandar lain
- New York City, NY10 kajian
- Washington, DC9 kajian
- Chicago, IL9 kajian
- Nashville, TN8 kajian
- Boston, MA8 kajian
- Arlington, VA6 kajian
- Philadelphia, PA6 kajian
- Pittsburgh, PA6 kajian
- Seattle, WA6 kajian
- Los Angeles, CA6 kajian
- Columbus, OH5 kajian
- Rochester, MN5 kajian
Kajian lain di Houston
- Kanser Paru-paru Bukan Sel Kecil145 kajian
- Kanser Payudara126 kajian
- Kanser (semua jenis)121 kajian
- Kanser Metastatik104 kajian
- Kanser Kolorektal102 kajian
- Kanser Ovari89 kajian
- Leukemia Mieloid Akut85 kajian
- Kanser Paru-paru78 kajian
- Kanser Prostat76 kajian
- Kanser Endometrium68 kajian
- Kanser Pankreas61 kajian
- Melanoma59 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.